SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-261686
Filing Date
2019-10-03
Accepted
2019-10-03 16:33:06
Documents
13
Period of Report
2019-09-27
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d808658d8k.htm   iXBRL 8-K 27751
  Complete submission text file 0001193125-19-261686.txt   180970

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA alny-20190927.xsd EX-101.SCH 3777
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alny-20190927_def.xml EX-101.DEF 13344
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE alny-20190927_lab.xml EX-101.LAB 21988
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alny-20190927_pre.xml EX-101.PRE 14275
14 EXTRACTED XBRL INSTANCE DOCUMENT d808658d8k_htm.xml XML 4706
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36407 | Film No.: 191136113
SIC: 2834 Pharmaceutical Preparations